Motilal Oswal's research report on Relaxo Footwears
Relaxo Footwears (Relaxo) posted a soft 5% YoY revenue growth, but improvement in GM and controlled cost translated into 21%/28% YoY growth in EBITDA/PAT (in line). Price cuts taken in the last couple of quarters have improved its competitive edge, driving a steep 15% volume growth YoY. Relaxo’s volume growth, led by price reduction, softening RM prices, and renewed focus on sports footwear should bolster the growth outlook. We have cut our estimates on the current weak macro environment and slow recovery, building revenue/PAT CAGR of 15%/34% over FY24-26. The stock is trading at 56x FY26E P/E and appears expensive in a soft earnings environment. We reiterate our Neutral stance on the stock.
Outlook
We ascribe a P/E of 55x on FY26E EPS to arrive at our TP of INR850 and reiterate our Neutral rating on the stock.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.